Logo image of XPON

EXPION360 INC (XPON) Stock Fundamental Analysis

NASDAQ:XPON - Nasdaq - US30218B2097 - Common Stock - Currency: USD

1.44  +0.04 (+2.86%)

After market: 1.4205 -0.02 (-1.35%)

Fundamental Rating

2

Overall XPON gets a fundamental rating of 2 out of 10. We evaluated XPON against 93 industry peers in the Electrical Equipment industry. XPON may be in some trouble as it scores bad on both profitability and health. XPON is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year XPON has reported negative net income.
XPON had a negative operating cash flow in the past year.
XPON Yearly Net Income VS EBIT VS OCF VS FCFXPON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -2M -4M -6M

1.2 Ratios

XPON has a Return On Assets of -152.18%. This is amonst the worse of the industry: XPON underperforms 89.13% of its industry peers.
XPON has a worse Return On Equity (-605.69%) than 77.17% of its industry peers.
Industry RankSector Rank
ROA -152.18%
ROE -605.69%
ROIC N/A
ROA(3y)-60.02%
ROA(5y)N/A
ROE(3y)-137.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XPON Yearly ROA, ROE, ROICXPON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 50 -50 -100 -150 -200

1.3 Margins

Looking at the Gross Margin, with a value of 20.49%, XPON is in line with its industry, outperforming 48.91% of the companies in the same industry.
In the last couple of years the Gross Margin of XPON has grown nicely.
The Profit Margin and Operating Margin are not available for XPON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.29%
GM growth 5YN/A
XPON Yearly Profit, Operating, Gross MarginsXPON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -50 -100

2

2. Health

2.1 Basic Checks

XPON does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for XPON has been reduced compared to 1 year ago.
Compared to 1 year ago, XPON has a worse debt to assets ratio.
XPON Yearly Shares OutstandingXPON Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M
XPON Yearly Total Debt VS Total AssetsXPON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -6.30, we must say that XPON is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -6.30, XPON is doing worse than 81.52% of the companies in the same industry.
XPON has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.08, XPON is in the better half of the industry, outperforming 66.30% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z -6.3
ROIC/WACCN/A
WACC7.12%
XPON Yearly LT Debt VS Equity VS FCFXPON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

XPON has a Current Ratio of 1.30. This is a normal value and indicates that XPON is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.30, XPON is doing worse than 71.74% of the companies in the same industry.
XPON has a Quick Ratio of 1.30. This is a bad value and indicates that XPON is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.80, XPON is not doing good in the industry: 69.57% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.8
XPON Yearly Current Assets VS Current LiabilitesXPON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M 10M

6

3. Growth

3.1 Past

XPON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -28.08%.
XPON shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.33%.
XPON shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 56.18% yearly.
EPS 1Y (TTM)-28.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.58%
Revenue 1Y (TTM)-31.33%
Revenue growth 3Y56.18%
Revenue growth 5YN/A
Sales Q2Q%-26.51%

3.2 Future

XPON is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.61% yearly.
Based on estimates for the next years, XPON will show a very strong growth in Revenue. The Revenue will grow by 20.70% on average per year.
EPS Next Y72.6%
EPS Next 2Y40.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-12.56%
Revenue Next 2Y20.7%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
XPON Yearly Revenue VS EstimatesXPON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
XPON Yearly EPS VS EstimatesXPON Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XPON. In the last year negative earnings were reported.
Also next year XPON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XPON Price Earnings VS Forward Price EarningsXPON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XPON Per share dataXPON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80 -100

4.3 Compensation for Growth

XPON's earnings are expected to grow with 40.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.61%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

XPON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EXPION360 INC

NASDAQ:XPON (2/21/2025, 8:00:02 PM)

After market: 1.4205 -0.02 (-1.35%)

1.44

+0.04 (+2.86%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)N/A N/A
Inst Owners0.46%
Inst Owner Change-29%
Ins Owners0.85%
Ins Owner Change0%
Market Cap3.70M
AnalystsN/A
Price Target4.08 (183.33%)
Short Float %13.24%
Short Ratio0.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-14.64%
Min EPS beat(2)-20.34%
Max EPS beat(2)-8.93%
EPS beat(4)0
Avg EPS beat(4)-12.6%
Min EPS beat(4)-20.34%
Max EPS beat(4)-8.54%
EPS beat(8)1
Avg EPS beat(8)-13.81%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.36%
Min Revenue beat(2)-26.55%
Max Revenue beat(2)-8.18%
Revenue beat(4)0
Avg Revenue beat(4)-15.96%
Min Revenue beat(4)-26.55%
Max Revenue beat(4)-8.18%
Revenue beat(8)1
Avg Revenue beat(8)-9.27%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-88.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9900%
EPS NY rev (1m)0.72%
EPS NY rev (3m)19.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.6%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.82
P/FCF N/A
P/OCF N/A
P/B 1.45
P/tB 1.45
EV/EBITDA N/A
EPS(TTM)-116.55
EYN/A
EPS(NY)-2.35
Fwd EYN/A
FCF(TTM)-3.11
FCFYN/A
OCF(TTM)-3.1
OCFYN/A
SpS1.75
BVpS0.99
TBVpS0.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -152.18%
ROE -605.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.49%
FCFM N/A
ROA(3y)-60.02%
ROA(5y)N/A
ROE(3y)-137.72%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.29%
GM growth 5YN/A
F-Score2
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.48%
Cap/Sales 0.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 0.8
Altman-Z -6.3
F-Score2
WACC7.12%
ROIC/WACCN/A
Cap/Depr(3y)183.13%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.58%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.58%
EPS Next Y72.6%
EPS Next 2Y40.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.33%
Revenue growth 3Y56.18%
Revenue growth 5YN/A
Sales Q2Q%-26.51%
Revenue Next Year-12.56%
Revenue Next 2Y20.7%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year14.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.12%
OCF growth 3YN/A
OCF growth 5YN/A